(Q51714855)

English

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

scientific article published in April 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

based on heuristic

inferred from title

Vasilis Karavasilis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Beatrice M Seddon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Susan Ashley

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Omar Al-Muderis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Cyril Fisher

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ian Judson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1585-1591

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Management of soft-tissue sarcomas: an overview and update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of surgery as primary treatment and as intervention in the multidisciplinary treatment of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Soft-tissue sarcomas in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential sensitivity of liposarcoma subtypes to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic therapy of soft tissue sarcoma: an improvement in outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23332

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23332

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278813%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51714855&oldid=1424773614"